Mix and Match Study of Two Multifocal Intraocular Lens With Different Add Power
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02556944|
Recruitment Status : Unknown
Verified September 2015 by tae-young chung, Samsung Medical Center.
Recruitment status was: Enrolling by invitation
First Posted : September 22, 2015
Last Update Posted : September 22, 2015
|Condition or disease||Intervention/treatment||Phase|
|Presbyopia||Device: Phacoemulsification with multifocal intraocular lens||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Mix and Match Study of Two Multifocal Intraocular Lens With Different Add Power|
|Study Start Date :||April 2015|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||April 2016|
Experimental: Mix and matched patients
Mix and matched patients will get phacoemulsification with multifocal intraocular lens implantation with two different add power (+2.75 diopters (D) or +3.25 D, respectively) in each eye of a patient, contralaterally.
Device: Phacoemulsification with multifocal intraocular lens
Phacoemulsification and implantation of a multifocal intraocular lens (IOL) with two different add power (+2.75 diopters (D) or +3.25 D, respectively) in each eye of a patient, contralaterally. They're called mix and matched patients.
- Visual acuity(Distant, intermediate, near) [ Time Frame: 1month ]
- Visual acuity(Distant, intermediate, near) [ Time Frame: 3month ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02556944
|Study Chair:||Tae-Young Chung, PhD||Samsung Medical Center|